The national independent specialty pharmacy DirectRx has joined the COPD Foundation’s Corporate Social Responsibility program to help support patients with chronic obstructive pulmonary disease (COPD) and find better treatments, . DirectRx’s membership brings to 23 the companies that fall under the foundation’s corporate sponsorship program. The program…
Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations and to improve lung function in people with chronic obstructive pulmonary disease (COPD), meeting the primary and key secondary goals of the pivotal Phase 3 BOREAS trial. A similarly…
Remote monitoring reduced hospitalization rates and emergency room visits for patients with chronic obstructive pulmonary disease (COPD), a recent study has shown. At the same time, outpatient office visits increased, suggesting remote patient monitoring may help shift care to a less expensive and burdensome setting. “These results support the…
Therapeutic Solutions International (TSOI) reported discovering a new mechanism of action for JadiCell, its investigative stem cell therapy for chronic obstructive pulmonary disease (COPD) and other conditions. Working in animal models, scientists found that JadiCell’s protective effects were dependent on certain immune B-cells and a signaling molecule…
The National Heart, Lung, and Blood Institute (NHLBI) has awarded $13 million for research focused on the link between the lung endothelium — a thin layer of cells, called endothelial cells, lining the inside of blood vessels in the lungs — and inflammation in lung diseases, including chronic obstructive…
The benefits of pulmonary rehabilitation in people with chronic obstructive pulmonary disease (COPD) may be tied to changes in oral microbiota, the natural community of microbes in the mouth, a study suggests. Pulmonary rehabilitation for 12 weeks prevented a drop in Rothia bacteria, known for their anti-inflammatory properties, and…
A screening questionnaire was able to identify “clinically significant” chronic obstructive pulmonary disease (COPD) in more than 40% of undiagnosed adults with the disease at that level taking part in a clinical trial, a recent study reported. Although further changes to the COPD Assessment in Primary Care to Identify Undiagnosed…
Kaia Health’s smartphone app, designed to help people with chronic obstructive pulmonary disease (COPD) manage their breathing symptoms at home, can now be prescribed by medical providers in Germany and is covered by statutory health insurance in that country, the company announced. The app, called Kaia COPD, offers…
Hospital admission rates for patients with chronic obstructive pulmonary disease (COPD) and asthma increased by 59.1% in England and Wales between 1999 and 2020, a 21-year follow-up study reported. COPD accompanied by acute lower respiratory infection accounted for 38.7% of hospital admissions, and more than half of admitted patients…
Biofourmis and Beacon Health System have partnered for an in-home monitoring program specifically meant for patients with complex chronic diseases, including chronic obstructive pulmonary disease (COPD), during their post-discharge period. Patient-reported data will be automatically collected, analyzed, and presented in a continuously updated dashboard visible to clinicians.
Get regular updates to your inbox.